Membrane Feeding Assay to Determine the Infectiousness of Plasmodium vivax Gametocytes
- 1 January 2015
- book chapter
- Published by Springer Nature
- Vol. 1325, 93-99
Abstract
The evaluation of Plasmodium vivax gametocyte infectiousness by the membrane feeding assay is herein described. While P. vivax cannot be cultured and different parasite isolates may infect mosquitoes at different rates, the protocol described in this chapter identifies critical parameters to be considered when performing the assay such as methods for the preparation of the mosquitoes, the size of the blood cup, and the blood volume used. In previous studies the data have shown that the membrane feeding assay is useful for studies of parasite biology, and the effects of transmission blocking drugs and vaccines.Keywords
This publication has 8 references indexed in Scilit:
- Susceptibility of Anopheles sinensis to Plasmodium vivax in malarial outbreak areas of central ChinaParasites & Vectors, 2013
- Mosquito Feeding Assays to Determine the Infectiousness of Naturally Infected Plasmodium falciparum Gametocyte CarriersPLOS ONE, 2012
- Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malariaVaccine, 2005
- COMPARISON OF ARTIFICIAL MEMBRANE FEEDING WITH DIRECT SKIN FEEDING TO ESTIMATE THE INFECTIOUSNESS OF PLASMODIUM VIVAX GAMETOCYTE CARRIERS TO MOSQUITOESThe American Journal of Tropical Medicine and Hygiene, 2003
- BLOCKING OF TRANSMISSION TO MOSQUITOES BY ANTIBODY TO PLASMODIUM VIVAX MALARIA VACCINE CANDIDATES PVS25 AND PVS28 DESPITE ANTIGENIC POLYMORPHISM IN FIELD ISOLATESThe American Journal of Tropical Medicine and Hygiene, 2003
- TRANSMISSION-BLOCKING ACTIVITY OF TAFENOQUINE (WR-238605) AND ARTELINIC ACID AGAINST NATURALLY CIRCULATING STRAINS OF PLASMODIUM VIVAX IN THAILANDThe American Journal of Tropical Medicine and Hygiene, 2003
- Prevention of sporogony of Plasmodium vivax in Anopheles dirus mosquitoes by transmission-blocking antimalarials.The American Journal of Tropical Medicine and Hygiene, 2001
- Antibodies to Malaria Vaccine Candidates Pvs25 and Pvs28 Completely Block the Ability ofPlasmodium vivaxTo Infect MosquitoesInfection and Immunity, 2000